The moldable bone graft substitute has osteoinductive properties for bone regeneration and will not wash away after placement in wet surgical environments, according to the release.
The Hospital for Special Surgery in New York conducted a study on the efficacy of OsteoSelect in a rabbit posterolateral lumbar spine fusion model. Bacterin paid for the study. Results showed the material’s control equal to that of autologous iliac crest bone grafts.
More Articles on Devices:
Biomet’s Net Sales Jump 6% in Q4, Year-End Sales Up 7.6%
Titan Spine Receives Patent for Surface Design of Interbody Fusion Implant
6 Top Planned Purchases for Physician Practices Over the Next Year
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
